Clinical Trial Update: Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania [Phase 4]

View source ↗

Summary

A Phase 4 trial in Tanzania compared single-dose versus two-week fluconazole for treating oropharyngeal candidiasis in HIV-infected patients; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Candidiasis

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

Sponsor: Netherlands Organisation for Scientific Research | Conditions: Oropharyngeal Candidiasis | Phase 4 | Status: COMPLETED